PubMed

Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy.

Sonpavde G, Goldman BH, Speights VO, Lerner SP, Wood DP, Vogelzang NJ, Trump DL, Natale RB, Grossman HB, Crawford ED.

Cancer. 2009 Sep 15;115(18):4104-9.PMID: 19517476 [PubMed - indexed for MEDLINE]Related articles

Vitamin D deficiency and insufficiency among patients with prostate cancer.

Trump DL, Chadha MK, Sunga AY, Fakih MG, Ashraf U, Silliman CG, Hollis BW, Nesline MK, Tian L, Tan W, Johnson CS.

BJU Int. 2009 Apr 4. [Epub ahead of print]PMID: 19426195 [PubMed - as supplied by publisher]Related articles

A phase I and pharmacokinetics study of intravenous calcitriol in combination with oral dexamethasone and gefitinib in patients with advanced solid tumors.

Muindi JR, Johnson CS, Trump DL, Christy R, Engler KL, Fakih MG.

Cancer Chemother Pharmacol. 2009 Dec;65(1):33-40. Epub 2009 Apr 26.PMID: 19396601 [PubMed - indexed for MEDLINE]Related articles

Bladder cancer.

Montie JE, Clark PE, Eisenberger MA, El-Galley R, Greenberg RE, Herr HW, Hudes GR, Kuban DA, Kuzel TM, Lange PH, Lele SM, Michalski J, Patterson A, Pohar KS, Richie JP, Sexton WJ, Shipley WU, Small EJ, Trump DL, Walther PJ, Wilson TG; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2009 Jan;7(1):8-39. No abstract available. PMID: 19176203 [PubMed - indexed for MEDLINE]Related articles

Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo.

Chung I, Han G, Seshadri M, Gillard BM, Yu WD, Foster BA, Trump DL, Johnson CS.

Cancer Res. 2009 Feb 1;69(3):967-75. Epub 2009 Jan 13.PMID: 19141646 [PubMed - indexed for MEDLINE]Related articles

Phase II study of Dutasteride for recurrent prostate cancer during androgen deprivation therapy.

Shah SK, Trump DL, Sartor O, Tan W, Wilding GE, Mohler JL.

J Urol. 2009 Feb;181(2):621-6. Epub 2008 Dec 16.PMID: 19091347 [PubMed - indexed for MEDLINE]Related articles

A dramatic, objective antiandrogen withdrawal response: case report and review of the literature.

Lau YK, Chadha MK, Litwin A, Trump DL.

J Hematol Oncol. 2008 Nov 5;1:21.PMID: 18986533 [PubMed - in process]Related articlesFree article

Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer.

Fakih MG, Trump DL, Johnson CS, Tian L, Muindi J, Sunga AY.

Int J Colorectal Dis. 2009 Feb;24(2):219-24. Epub 2008 Oct 2.PMID: 18830610 [PubMed - indexed for MEDLINE]Related articles

Skeletal health after continuation, withdrawal, or delay of alendronate in men with prostate cancer undergoing androgen-deprivation therapy.

Greenspan SL, Nelson JB, Trump DL, Wagner JM, Miller ME, Perera S, Resnick NM.

J Clin Oncol. 2008 Sep 20;26(27):4426-34.PMID: 18802155 [PubMed - indexed for MEDLINE]Related articlesFree article

1alpha,25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma model.

Ma Y, Yu WD, Hershberger PA, Flynn G, Kong RX, Trump DL, Johnson CS.

Mol Cancer Ther. 2008 Sep;7(9):3047-55.PMID: 18790784 [PubMed - indexed for MEDLINE]Related articlesFree article

Phase II study of fulvestrant (Faslodex) in castration resistant prostate cancer.

Chadha MK, Ashraf U, Lawrence D, Tian L, Levine E, Silliman C, Escott P, Payne V, Trump DL.

Prostate. 2008 Sep 15;68(13):1461-6.PMID: 18618738 [PubMed - indexed for MEDLINE]Related articles

Phenotype-specific CpG island methylation events in a murine model of prostate cancer.

Camoriano M, Kinney SR, Moser MT, Foster BA, Mohler JL, Trump DL, Karpf AR, Smiraglia DJ.

Cancer Res. 2008 Jun 1;68(11):4173-82.PMID: 18519676 [PubMed - indexed for MEDLINE]Related articlesFree article

In vitro and in vivo evaluation of combined calcitriol and cisplatin in dogs with spontaneously occurring tumors.

Rassnick KM, Muindi JR, Johnson CS, Balkman CE, Ramnath N, Yu WD, Engler KL, Page RL, Trump DL.

Cancer Chemother Pharmacol. 2008 Oct;62(5):881-91. Epub 2008 Feb 2.PMID: 18246349 [PubMed - indexed for MEDLINE]Related articlesFree article

Vitamin D signalling pathways in cancer: potential for anticancer therapeutics.

Deeb KK, Trump DL, Johnson CS.

Nat Rev Cancer. 2007 Sep;7(9):684-700. Review.PMID: 17721433 [PubMed - indexed for MEDLINE]Related articles

Trastuzumab, paclitaxel, carboplatin, and gemcitabine in advanced human epidermal growth factor receptor-2/neu-positive urothelial carcinoma: results of a multicenter phase II National Cancer Institute trial.

Hussain MH, MacVicar GR, Petrylak DP, Dunn RL, Vaishampayan U, Lara PN Jr, Chatta GS, Nanus DM, Glode LM, Trump DL, Chen H, Smith DC; National Cancer Institute.

J Clin Oncol. 2007 Jun 1;25(16):2218-24. Erratum in: J Clin Oncol. 2008 Jul 1;26(19): 3295. PMID: 17538166 [PubMed - indexed for MEDLINE]Related articles

Docetaxel-induced Meibomian duct inflammation and blockage leading to chalazion formation.

Gupta S, Silliman CG, Trump DL.

Prostate Cancer Prostatic Dis. 2007;10(4):396-7. Epub 2007 Apr 3.PMID: 17404582 [PubMed - indexed for MEDLINE]Related articles

Effect of once-weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for prostate cancer: a randomized trial.

Greenspan SL, Nelson JB, Trump DL, Resnick NM.

Ann Intern Med. 2007 Mar 20;146(6):416-24.PMID: 17371886 [PubMed - indexed for MEDLINE]Related articlesFree article

Anti-proliferative effects of calcitriol on endothelial cells derived from two different microenvironments.

Chung I, Yu WD, Karpf AR, Flynn G, Bernardi RJ, Modzelewski RA, Johnson CS, Trump DL.

J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):768-70. Review.PMID: 17368191 [PubMed - indexed for MEDLINE]Related articles

Altered VDR-mediated transcriptional activity in prostate cancer stroma.

Hidalgo AA, Paredes R, Garcia VM, Flynn G, Johnson CS, Trump DL, Onate SA.

J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):731-6.PMID: 17368189 [PubMed - indexed for MEDLINE]Related articles

CYP24 splicing variants are associated with different patterns of constitutive and calcitriol-inducible CYP24 activity in human prostate cancer cell lines.

Muindi JR, Nganga A, Engler KL, Coignet LJ, Johnson CS, Trump DL.

J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):334-7.PMID: 17368180 [PubMed - indexed for MEDLINE]Related articles

A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors.

Fakih MG, Trump DL, Muindi JR, Black JD, Bernardi RJ, Creaven PJ, Schwartz J, Brattain MG, Hutson A, French R, Johnson CS.

Clin Cancer Res. 2007 Feb 15;13(4):1216-23.PMID: 17317832 [PubMed - indexed for MEDLINE]Related articlesFree article

Characterization of Vitamin D insensitive prostate cancer cells.

Alagbala AA, Moser MT, Johnson CS, Trump DL, Foster BA.

J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):712-6. Epub 2007 Feb 5.PMID: 17280828 [PubMed - indexed for MEDLINE]Related articlesFree article

Epigenetic silencing of CYP24 in tumor-derived endothelial cells contributes to selective growth inhibition by calcitriol.

Chung I, Karpf AR, Muindi JR, Conroy JM, Nowak NJ, Johnson CS, Trump DL.

J Biol Chem. 2007 Mar 23;282(12):8704-14. Epub 2007 Jan 22.PMID: 17244627 [PubMed - indexed for MEDLINE]Related articlesFree article

Antitumor effects of two less-calcemic vitamin D analogs (Paricalcitol and QW-1624F2-2) in squamous cell carcinoma cells.

Alagbala AA, Johnson CS, Trump DL, Posner GH, Foster BA.

Oncology. 2006;70(6):483-92. Epub 2007 Jan 18.PMID: 17237623 [PubMed - indexed for MEDLINE]Related articles

Calcitriol (1,25-dihydroxycholecalciferol) selectively inhibits proliferation of freshly isolated tumor-derived endothelial cells and induces apoptosis.

Flynn G, Chung I, Yu WD, Romano M, Modzelewski RA, Johnson CS, Trump DL.

Oncology. 2006;70(6):447-57. Epub 2007 Jan 19.PMID: 17237620 [PubMed - indexed for MEDLINE]Related articles

Bladder cancer. Clinical guidelines in oncology.

Montie JE, Abrahams NA, Bahnson RR, Eisenberger MA, El-Galley R, Herr HW, Hudes GR, Kuzel TM, Lange PH, Patterson A, Pollack A, Richie JP, Sexton WJ, Shipley WU, Small EJ, Trump DL, Walther PJ, Wilson TG; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2006 Nov;4(10):984-1014. No abstract available. PMID: 17112448 [PubMed - indexed for MEDLINE]Related articles

Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancer.

Beer TM, Javle MM, Ryan CW, Garzotto M, Lam GN, Wong A, Henner WD, Johnson CS, Trump DL.

Cancer Chemother Pharmacol. 2007 Apr;59(5):581-7. Epub 2006 Oct 26.PMID: 17066293 [PubMed - indexed for MEDLINE]Related articles

Differential antiproliferative effects of calcitriol on tumor-derived and matrigel-derived endothelial cells.

Chung I, Wong MK, Flynn G, Yu WD, Johnson CS, Trump DL.

Cancer Res. 2006 Sep 1;66(17):8565-73.PMID: 16951169 [PubMed - indexed for MEDLINE]Related articlesFree article

Role of nongenomic activation of phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase 1/2 pathways in 1,25D3-mediated apoptosis in squamous cell carcinoma cells.

Ma Y, Yu WD, Kong RX, Trump DL, Johnson CS.

Cancer Res. 2006 Aug 15;66(16):8131-8.PMID: 16912191 [PubMed - indexed for MEDLINE]Related articlesFree article

Vitamin D compounds: clinical development as cancer therapy and prevention agents.

Trump DL, Muindi J, Fakih M, Yu WD, Johnson CS.

Anticancer Res. 2006 Jul-Aug;26(4A):2551-6.PMID: 16886663 [PubMed - indexed for MEDLINE]Related articles

The antitumor efficacy of calcitriol: preclinical studies.

Johnson CS, Muindi JR, Hershberger PA, Trump DL.

Anticancer Res. 2006 Jul-Aug;26(4A):2543-9. Review.PMID: 16886662 [PubMed - indexed for MEDLINE]Related articles

Peroxisome proliferator-activated receptor-gamma polymorphism, body mass and prostate cancer risk: evidence for gene-environment interaction.

Zmuda JM, Modugno F, Weissfeld JL, Cauley JA, Trump DL, Moffett SP, Ferrell RE.

Oncology. 2006;70(3):185-9. Epub 2006 Jun 7.PMID: 16763406 [PubMed - indexed for MEDLINE]Related articles

Monocyte fructose 1,6-bisphosphatase and cytidine deaminase enzyme activities: potential pharmacodynamic measures of calcitriol effects in cancer patients.

Muindi JR, Peng Y, Wilson JW, Johnson CS, Branch RA, Trump DL.

Cancer Chemother Pharmacol. 2007 Jan;59(1):97-104. Epub 2006 May 6.PMID: 16680461 [PubMed - indexed for MEDLINE]Related articles

Stat3 activation of NF-{kappa}B p100 processing involves CBP/p300-mediated acetylation.

Nadiminty N, Lou W, Lee SO, Lin X, Trump DL, Gao AC.

Proc Natl Acad Sci U S A. 2006 May 9;103(19):7264-9. Epub 2006 May 1.PMID: 16651533 [PubMed - indexed for MEDLINE]Related articlesFree article

Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).

Lee SO, Yeon Chun J, Nadiminty N, Trump DL, Ip C, Dong Y, Gao AC.

Prostate. 2006 Jul 1;66(10):1070-5.PMID: 16637076 [PubMed - indexed for MEDLINE]Related articles

Phase II trial of high-dose, intermittent calcitriol (1,25 dihydroxyvitamin D3) and dexamethasone in androgen-independent prostate cancer.

Trump DL, Potter DM, Muindi J, Brufsky A, Johnson CS.

Cancer. 2006 May 15;106(10):2136-42.PMID: 16598750 [PubMed - indexed for MEDLINE]Related articlesFree article

Pharmacokinetics and tolerability of a single dose of DN-101, a new formulation of calcitriol, in patients with cancer.

Beer TM, Javle M, Lam GN, Henner WD, Wong A, Trump DL.

Clin Cancer Res. 2005 Nov 1;11(21):7794-9.PMID: 16278401 [PubMed - indexed for MEDLINE]Related articlesFree article

Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer.

Greenspan SL, Coates P, Sereika SM, Nelson JB, Trump DL, Resnick NM.

J Clin Endocrinol Metab. 2005 Dec;90(12):6410-7. Epub 2005 Sep 27.PMID: 16189261 [PubMed - indexed for MEDLINE]Related articlesFree article

Phase I and pharmacokinetic study of the novel redox-active agent, motexafin gadolinium, with concurrent radiation therapy in patients with locally advanced pancreatic or biliary cancers.

Ramanathan RK, Fakih M, Mani S, Deutsch M, Perez RP, Ritter MA, Eiseman JL, Ivy SP, Trump DL, Belani CP, Parise RA, Potter DM, Egorin MJ.

Cancer Chemother Pharmacol. 2006 Apr;57(4):465-74. Epub 2005 Aug 25.PMID: 16133531 [PubMed - indexed for MEDLINE]Related articles

Interleukin-6 polymorphism is associated with more aggressive prostate cancer.

Tan D, Wu X, Hou M, Lee SO, Lou W, Wang J, Janarthan B, Nallapareddy S, Trump DL, Gao AC.

J Urol. 2005 Aug;174(2):753-6.PMID: 16006970 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetics of liquid calcitriol formulation in advanced solid tumor patients: comparison with caplet formulation.

Muindi JR, Potter DM, Peng Y, Johnson CS, Trump DL.

Cancer Chemother Pharmacol. 2005 Nov;56(5):492-6. Epub 2005 May 26.PMID: 15918041 [PubMed - indexed for MEDLINE]Related articles

Phase I pharmacokinetic-pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin (17AAG, NSC 330507), a novel inhibitor of heat shock protein 90, in patients with refractory advanced cancers.

Ramanathan RK, Trump DL, Eiseman JL, Belani CP, Agarwala SS, Zuhowski EG, Lan J, Potter DM, Ivy SP, Ramalingam S, Brufsky AM, Wong MK, Tutchko S, Egorin MJ.

Clin Cancer Res. 2005 May 1;11(9):3385-91.PMID: 15867239 [PubMed - indexed for MEDLINE]Related articlesFree article

Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species.

Singh SV, Srivastava SK, Choi S, Lew KL, Antosiewicz J, Xiao D, Zeng Y, Watkins SC, Johnson CS, Trump DL, Lee YJ, Xiao H, Herman-Antosiewicz A.

J Biol Chem. 2005 May 20;280(20):19911-24. Epub 2005 Mar 11.PMID: 15764812 [PubMed - indexed for MEDLINE]Related articlesFree article

Bladder cancer. Clinical practice guidelines in oncology.

Montie JE, Bahnson RR, Cohen SM, Drucker B, Eisenberger MA, El-Galley R, Herr HW, Hudes GR, Kuzel TM, Lange PH, Patterson A, Pollack A, Richie JP, Seigne J, Shipley WU, Small EJ, Trump DL, Walther PJ, Wilson TG; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2005 Jan;3(1):4-5, 19-34.PMID: 19813320 [PubMed - in process]

Population pharmacokinetic analysis of 17-(allylamino)-17-demethoxygeldanamycin (17AAG) in adult patients with advanced malignancies.

Chen X, Bies RR, Ramanathan RK, Zuhowski EG, Trump DL, Egorin MJ.

Cancer Chemother Pharmacol. 2005 Mar;55(3):237-43. Epub 2004 Oct 19.PMID: 15503027 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetic studies of 9-nitrocamptothecin on intermittent and continuous schedules of administration in patients with solid tumors.

Jung LL, Ramanathan RK, Egorin MJ, Jin R, Belani CP, Potter DM, Strychor S, Trump DL, Walko C, Fakih M, Zamboni WC.

Cancer Chemother Pharmacol. 2004 Dec;54(6):487-96. Epub 2004 Aug 18.PMID: 15322760 [PubMed - indexed for MEDLINE]Related articles

Phase I and pharmacologic study of intermittently administered 9-nitrocamptothecin in patients with advanced solid tumors.

Zamboni WC, Jung LL, Egorin MJ, Potter DM, Friedland DM, Belani CP, Agarwala SS, Wong MM, Fakih M, Trump DL, Jin R, Strychor S, Vozniak M, Troetschel M, Ramanathan RK.

Clin Cancer Res. 2004 Aug 1;10(15):5058-64.PMID: 15297407 [PubMed - indexed for MEDLINE]Related articlesFree article

RNA interference targeting Stat3 inhibits growth and induces apoptosis of human prostate cancer cells.

Lee SO, Lou W, Qureshi KM, Mehraein-Ghomi F, Trump DL, Gao AC.

Prostate. 2004 Sep 1;60(4):303-9.PMID: 15264241 [PubMed - indexed for MEDLINE]Related articles

Anti-tumor activity of calcitriol: pre-clinical and clinical studies.

Trump DL, Hershberger PA, Bernardi RJ, Ahmed S, Muindi J, Fakih M, Yu WD, Johnson CS.

J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):519-26. Review.PMID: 15225831 [PubMed - indexed for MEDLINE]Related articles

Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2.

Xiao D, Choi S, Johnson DE, Vogel VG, Johnson CS, Trump DL, Lee YJ, Singh SV.

Oncogene. 2004 Jul 22;23(33):5594-606.PMID: 15184882 [PubMed - indexed for MEDLINE]Related articles